Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes.

Authors: Hennige, AM  Burks, DJ  Ozcan, U  Kulkarni, RN  Ye, J  Park, S  Schubert, M  Fisher, TL  Dow, MA  Leshan, R  Zakaria, M  Mossa-Basha, M  White, MF 
Citation: Hennige AM, etal., J Clin Invest. 2003 Nov;112(10):1521-32.
Pubmed: (View Article at PubMed) PMID:14617753
DOI: Full-text: DOI:10.1172/JCI18581

The insulin receptor substrate-2 (Irs2) branch of the insulin/IGF signaling system coordinates peripheral insulin action and pancreatic beta cell function, so mice lacking Irs2 display similarities to humans with type 2 diabetes. Here we show that beta cell-specific expression of Irs2 at a low or a high level delivered a graded physiologic response that promoted beta cell growth, survival, and insulin secretion that prevented diabetes in Irs2-/- mice, obese mice, and streptozotocin-treated mice; and that upon transplantation, the transgenic islets cured diabetes more effectively than WT islets. Thus, pharmacological approaches that promote Irs2 expression in beta cells, especially specific cAMP agonists, could be rational treatments for beta cell failure and diabetes.

Annotation

Disease Annotations
Objects Annotated

Additional Information

 
RGD Object Information
RGD ID: 10045938
Created: 2015-06-24
Species: All species
Last Modified: 2015-06-24
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.